SciClone Biomedical Technology Co., Ltd. 2025 Q4 Financial Report
NQ Score
60/100
N1 Content Completeness
8
AI Summary (NQ-processed)
SciClone Biomedical Technology Co., Ltd. reported an operating revenue of 0.30 billion NTD and a net loss of 1.15 billion NTD for Q4 2025, with basic EPS at -1.89 NTD.
AI analysis data is not yet available.